Clinical impact of isolated mediastinal and hilar lymphadenopathy (IMHL). Insights from thoracic endosonography (EBUS/EUS-b).
S. Chrysikos (Athens, Greece), T. Karampitsakos (Patra, Greece), S. Koukidou (Athens, Greece), A. Papaporphyriou (Athens, Greece), M. Anyfanti (Athens, Greece), E. Zervas (Athens, Greece), G. Hillas (Athens, Greece), A. Tzouvelekis (Patra, Greece), K. Dimakou (Athens, Greece)
Source: International Congress 2022 – Cutting-edge concepts in interventional bronchoscopy
Session: Cutting-edge concepts in interventional bronchoscopy
Session type: Thematic Poster
Number: 2697
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chrysikos (Athens, Greece), T. Karampitsakos (Patra, Greece), S. Koukidou (Athens, Greece), A. Papaporphyriou (Athens, Greece), M. Anyfanti (Athens, Greece), E. Zervas (Athens, Greece), G. Hillas (Athens, Greece), A. Tzouvelekis (Patra, Greece), K. Dimakou (Athens, Greece). Clinical impact of isolated mediastinal and hilar lymphadenopathy (IMHL). Insights from thoracic endosonography (EBUS/EUS-b).. 2697
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|